Tai, Cheng-Jeng <br/><br/>
Bevacizumab and cetuximab with conventional chemotherapy reduced pancreatic tumor weight in mouse pancreatic cancer xenografts.  [electronic resource] 

 -  Clinical and experimental medicine  May 2017 
 - 141-150 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1591-9528 
<br/><br/><label>Standard No.: </label>10.1007/s10238-016-0409-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Bevacizumab--administration & dosage<br/>Cetuximab--administration & dosage<br/>Disease Models, Animal<br/>Drug Therapy--methods<br/>Drug Therapy, Combination--methods<br/>Female<br/>Heterografts<br/>Humans<br/>Mice, Inbred BALB C<br/>Pancreatic Neoplasms--drug therapy<br/>Treatment Outcome<br/>Tumor Burden